Position in VRTX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$1,259,689
+$163,465 QoQ
Shares Held
2,821
+16.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Simplicity Wealth,LLC holds $2,705,112 across 8 Biotechnology names. VRTX ranks #1 (46.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,821 | $1,259,689 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
947 | $731,690 | |
| 3 | CELC |
Celcuity Inc.
|
4,171 | $476,077 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
28,350 | $149,971 | |
| 5 | ANIX |
Anixa Biosciences Inc
|
12,000 | $30,960 | |
| 6 | CCCC |
C4 Therapeutics, Inc.
|
10,201 | $26,828 | |
| 7 | CDXS |
Codexis, Inc.
|
13,308 | $21,692 | |
| 8 | GNTA |
Genenta Science S.p.A.
|
12,211 | $8,205 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,259,689 | 2,821 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,096,224 | 2,418 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $788,371 | 2,013 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,351,182 | 3,035 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $629,781 | 1,299 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $289,138 | 718 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $297,186 | 639 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $12,954,014 | 27,637 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $11,907,850 | 28,487 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||